Ann Dermatol.  2017 Aug;29(4):499-500. 10.5021/ad.2017.29.4.499.

A Case of Wolf's Isotopic Response Presenting as Bullous Pemphigoid

• Chun SH
• Kim BY
• Kim CM
• Park JB
• Ryu HJ

• KMID: 2388955
• DOI: http://doi.org/10.5021/ad.2017.29.4.499

Abstract

No abstract available.

MeSH Terms

Pemphigoid, Bullous*

Figure

• 

  Fig. 1 Erythematous patch, bullae, and ulceration on right T3 dermatome.

• 

  Fig. 2 (A) Subepithelial vesicles with dermal infiltration of lymphocytes, histiocytes, and eosinophils (H&E, ×100). (B) Direct immunofluorescence reveal linear deposition of immunoglobulin G in basement membrane zone.

Reference

1. Ruocco V, Ruocco E, Brunetti G, Russo T, Gambardella A, Wolf R. Wolf's post-herpetic isotopic response: Infections, tumors, and immune disorders arising on the site of healed herpetic infection. Clin Dermatol. 2014; 32:561–568.

2. Noh TW, Park SH, Kang YS, Lee UH, Park HS, Jang SJ. Morphea developing at the site of healed herpes zoster. Ann Dermatol. 2011; 23:242–245.

3. Gurel MS, Savas S, Bilgin F, Erdil D, Leblebici C, Sarikaya E. Zosteriform pemphigoid after zoster: Wolf's isotopic response. Int Wound J. 2016; 13:141–142.

4. Fichel F, Barbe C, Joly P, Bedane C, Vabres P, Truchetet F, et al. Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study. JAMA Dermatol. 2014; 150:25–33.

5. Kamiya K, Aoyama Y, Suzuki T, Niwa H, Horio A, Nishio E, et al. Possible enhancement of BP180 autoantibody production by herpes zoster. J Dermatol. 2016; 43:197–199.